NCT02928549
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Primary Peritoneal Cancer
Explore clinical trials studying Primary Peritoneal Cancer. Study availability and eligibility vary by location and protocol.
91 public trials
21 recruiting studies
Primary Peritoneal Cancer trial results
- Conditions
- Adnexal Diseases, Clear Cell Mullerian Tumor, Endocrine Gland Neoplasms, +19 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01652079
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00428610
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, United States
Completed
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT01219777
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- The Ohio State University Medical Center Columbus, Ohio, United States
NCT01339650
- Conditions
- Fallopian Tube, Fanconi Anemia, Complementation Group D1, Primary Peritoneal Cancer, +1 more
- Locations
-
- Univ Med Center Groningen Groningen, Netherlands
- Univ Med Ctr, St. Radboud Nijmegen, Netherlands
- Erasmus Medisch Centrum Rotterdam, Netherlands
NCT01105650
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +22 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
NCT00526617
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +41 more
- Locations
-
Not specified
Completed
Phase II ABT-888 With Cyclophosphamide
NCT01306032
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +24 more
- Locations
-
- University of California, Davis Davis, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
- University of Chicago Chicago, Illinois, United States
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01204749
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site San Diego, California, United States
- Research Site Stanford, California, United States